| Her-2/neu蛋白抑制剂在胃癌化疗中的应用 |
| |
| 引用本文： | 田晓云,孙国平. Her-2/neu蛋白抑制剂在胃癌化疗中的应用[J]. 安徽医药, 2010, 14(4): 467-470. DOI: 10.3969/j.issn.1009-6469.2010.04.047 |
| |
| 作者姓名： | 田晓云 孙国平 |
| |
| 作者单位： | 安徽医科大学第一附属医院肿瘤内科,安徽,合肥,230022;安徽医科大学第一附属医院肿瘤内科,安徽,合肥,230022 |
| |
| 摘 要： | 胃癌在世界范围内死亡率居于第二位，但其治疗尤其是进展期胃癌治疗，迄今尚无有效的标准方案。Her-2／neu蛋白是原癌基因Her-2／neu编码的一种具有酪氨酸激酶活性的跨膜糖蛋白。在胃癌的发生、发展和侵袭性转移性上发挥着重要作用。约5．6％-30％的胃癌存在Her-2／neu蛋白过度表达。Her-2／neu蛋白过度表达与胃癌患者生存期相关，可作为预后因素。各种体内体外的临床前期试验表明抗Her-2／neu治疗的有效性，多种设计不同的临床试验也证实了抗Her-2／neu蛋白治疗在胃癌化疗中的潜力。
|
| 关 键 词： | Her-2/neu 胃癌 Her-2/neu抑制剂 赫赛汀 |
HER2/neu protein inhibitors in gastric cancer chemotherapy |
| |
| TIAN Xiao-yun,SUN Guo-ping. HER2/neu protein inhibitors in gastric cancer chemotherapy[J]. Anhui Medical and Pharmaceutical Journal, 2010, 14(4): 467-470. DOI: 10.3969/j.issn.1009-6469.2010.04.047 |
| |
| Authors: | TIAN Xiao-yun SUN Guo-ping |
| |
| Affiliation: | The First Affiliated Hospital of Anhui Medical University;Hefei 230022 |
| |
| Abstract: | Gastric cancer is the second leading cause of cancer mortality in the world and its management,especially in advanced stages,has evolved relatively little.In particular,no targeted modality has so far been incorporated to its treatment armamentarium.HER2/neu proto-oncogene HER2/neu protein is encoded in a kind of tyrosine kinase activity transmembrane glycoprotein.In the gastric cancer occurrence,development and invasive metastatic play an important role.About 5.6% to 30% of the HER2/neu protein overexpress... |
| |
| Keywords: | HER2/neu gastric cancer HER2 prognostic factor trastuzumab |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
